Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reboxetine effects on the exploitation-exploration trade-off in healthy volunteers
NL-OMON31488Active, not recruiting
- Sponsor
- Centre for Human Drug Research
- Start
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of reboxetine and citalopram (3 arms), sponsored by Centre for Human Drug Research. Primary endpoint: Performance on cognitive tasks assessing exploitative and explorative behavior. Started Jan 2009; status: active, not recruiting.
02
Drugs
reboxetinecitalopram
Beyond the preview
Go deeper on NL-OMON31488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON31488.